Skip to the page

Data / Medical devices / United States / Neomedico, LLC

Neomedico, LLC: FDA-registered device maker in Cheyenne, WY, United States, 17 PMA approvals

Neomedico, LLC is registered with the FDA (registration 3042708459) in Cheyenne, WY, United States. It lists 3 device types. The FDA files 17 PMA approvals under its listings, the newest dated October 19, 2017. Registered through 2026. FDA data exported November 2, 2026.

SpecStream is the live web data engine for teams and agents. It reads the FDA registration and listing, 510(k), PMA, recall and enforcement files from openFDA every week, and this page is that reading, joined by the FDA's own numbers. Ask for the makers of any device type in any country and new clearances, approvals and recalls arrive in your sheet, CRM, Slack or agent as the FDA publishes them.

FDA registration number
3042708459
Address
1408 E 13th Street, Cheyenne, WY, United States, 82001
Owner or operator
Neomedico, Inc. (10094958)
Roles
Repackager or relabeler
First device listed
January 9, 2026
Registered through
2026
Brand names listed
BELOTERO BALANCE, BELOTERO BALANCE WITH LIDOCAINE, DUROLANE, EUFLEXXA, HYALGAN, HYMOVIS, JUVEDERM ULTRA PLUS XC, JUVEDERM ULTRA XC and more

Devices it lists

DeviceProduct codeClassRoleSource
Acid, Hyaluronic, IntraarticularMOZ3Repackager or relabeleraccessdata.fda.gov
Implant, Dermal, For Aesthetic UseLMH3Repackager or relabeleraccessdata.fda.gov
Implant, Dermal, For Aesthetic Use In The HandsPKY3Repackager or relabeleraccessdata.fda.gov

PMA approvals

Premarket approvals this establishment lists, with the supplements the FDA has decided since.

ApprovedPMA numberDeviceProduct codeSupplementsLatest decisionSource
October 19, 2017P170002RHA 2, RHA 3, RHA 4LMH55August 31, 2026accessdata.fda.gov
August 29, 2017P170007DUROLANEMOZ15December 23, 2025accessdata.fda.gov
December 9, 2016P140029Restylane Refyne, Restylane DefyneLMH51September 18, 2026accessdata.fda.gov
August 28, 2015P150010HYMOVISMOZ5April 9, 2025accessdata.fda.gov
February 25, 2014P090031MONOVISCMOZ15August 8, 2023accessdata.fda.gov
October 22, 2013P110033JUVEDERM VOLUMA XCLMH97August 28, 2026accessdata.fda.gov
November 14, 2011P090016BELOTERO BALANCELMH60May 3, 2026accessdata.fda.gov
December 22, 2006P050052RADIESSE INJECTABLE IMPLANTLMH169June 26, 2026accessdata.fda.gov
December 22, 2006P050037RADIESSE 1.3CC AND 0.3CCLMH147June 26, 2026accessdata.fda.gov
June 2, 2006P050047JUVEDERM 24HV, JUVEDERM 30 AND JUVEDERM 30HV GEL IMPLANTSLMH101August 28, 2026accessdata.fda.gov
March 25, 2005P040024RESTYLANE INJECTABLE GELLMH132March 12, 2026accessdata.fda.gov
December 3, 2004P010029EUFLEXXA (1% SODIUM HYALURONATE)MOZ40September 2, 2026accessdata.fda.gov
August 3, 2004P030050SCULPTRA AND SCULPTRA AESTHETICLMH54September 17, 2026accessdata.fda.gov
February 4, 2004P030019ORTHOVISC HIGH MOLECULAR WEIGHT HYALURONANMOZ23August 28, 2026accessdata.fda.gov
January 24, 2001P980044SUPARTZ FXMOZ62September 4, 2026accessdata.fda.gov
August 8, 1997P940015SYNVISC ONEMOZ51January 2, 2025accessdata.fda.gov
May 28, 1997P950027HYALGAN(R)MOZ15June 28, 2024accessdata.fda.gov

Compare with other makers

Updated August 31, 2026. Read from openFDA bulk downloads (device registration and listing, 510(k), PMA, recall and enforcement files). CC0 1.0, public domain (openFDA terms of service). The files are joined on FDA identifiers: the 510(k) and PMA numbers a registration lists, and the recalling firm's FEI for recalls. Recall class comes from the FDA enforcement report. The FDA states that openFDA data is unvalidated and is not for decisions about medical care. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.